Ciro Rodriguez Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ciro Rodriguez Diaz has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Álvaro Somoza
IMDEA Nanociencia, Madrid, Spain
6 shared publications - Paula Milán-Rois
IMDEA Nanociencia, Madrid, Spain
4 shared publications - Milagros Castellanos
Fundacion IMDEA Nanociencia, Madrid, SPAIN
3 shared publications - Nuria Lafuente-Gómez
Fundacion IMDEA Nanociencia, Madrid, SPAIN
3 shared publications - Alfonso Latorre
Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Faraday 9, 28049 Madrid, Spain
2 shared publications Hernán Alarcón-Iniesta
Fundacion IMDEA Nanociencia, Madrid, SPAIN
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 10 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles
Inefficient targeting of muscle stem cells (MuSCs), also called satellite cells, represents a major bottleneck of current therapeutic strategies for muscular dystrophies, as it precludes the possibility of promoting compensatory regeneration. Here we describe a muscle-targeting delivery platform, based on gold nanoparticles, that enables the release of therapeutic oligonucleotides into MuSCs. We demonstrate that AuNPs conjugation to an aptamer against α7/β1 integrin dimers directs either local or systemic delivery of microRNA-206 to MuSCs, thereby promoting muscle regeneration and improving muscle functionality, in a mouse model of Duchenne Muscular Dystrophy. We show here that this platform is biocompatible, non-toxic, and non-immunogenic, and it can be easily adapted for the release of a wide range of therapeutic oligonucleotides into diseased muscles.
- 10 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Top Cited PapersOpen AccessAptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles
Inefficient targeting of muscle stem cells (MuSCs), also called satellite cells, represents a major bottleneck of current therapeutic strategies for muscular dystrophies, as it precludes the possibility of promoting compensatory regeneration. Here we describe a muscle-targeting delivery platform, based on gold nanoparticles, that enables the release of therapeutic oligonucleotides into MuSCs. We demonstrate that AuNPs conjugation to an aptamer against α7/β1 integrin dimers directs either local or systemic delivery of microRNA-206 to MuSCs, thereby promoting muscle regeneration and improving muscle functionality, in a mouse model of Duchenne Muscular Dystrophy. We show here that this platform is biocompatible, non-toxic, and non-immunogenic, and it can be easily adapted for the release of a wide range of therapeutic oligonucleotides into diseased muscles.
- Open Access
- 31 December 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1338, 343601
CRISPR-associated Plasmonic Colorimeter Method (Ca-PCM): A real-time RGB detection system for gold nanoparticles-based nucleic acid biosensors
- 31 December 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1338, 343601
Open AccessCRISPR-associated Plasmonic Colorimeter Method (Ca-PCM): A real-time RGB detection system for gold nanoparticles-based nucleic acid biosensors
- 29 July 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (31) , 11129-11138
Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
The interactions of magnetic nanoparticles with blood components must be carefully assessed to select nanoparticles for biomedical applications. Remarkably, MNP's surface can be tuned to add and enhance immunomodulatory properties in macrophages.
- 29 July 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (31) , 11129-11138
Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
The interactions of magnetic nanoparticles with blood components must be carefully assessed to select nanoparticles for biomedical applications. Remarkably, MNP's surface can be tuned to add and enhance immunomodulatory properties in macrophages.
- Open Access
Development of colorimetric sensors based on gold nanoparticles for SARS-CoV-2 RdRp, E and S genes detection
- 7 December 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (100) , 13662-13677
Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications
This comprehensive feature article summarizes the recent progress of controlled release systems based on nanostructures for cancer treatment.
- 7 December 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (100) , 13662-13677
Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications
This comprehensive feature article summarizes the recent progress of controlled release systems based on nanostructures for cancer treatment.
- 4 October 2019
- Published by Wiley in Chemistry – A European Journal
- Vol. 25 (66) , 15050-15054
Light‐Induced Tetrazole‐Quinone 1,3‐Dipolar Cycloadditions
Quinones were firstly used as dipolarophiles in a photoclick 1,3‐cycloaddition with 2,5‐diaryltetrazoles, as photoactivatable predipoles, providing a novel and efficient access to three types of pyrazole‐fused quinones (indazoledione derivatives). Distinctive features of this protocol include the use of light as the unique reagent and readily available, stable, and easy to handle starting materials and good to excellent yields. Photophysical and electrochemical properties of the quinones and their potential application as photoredox catalysts are also detailed.
- 4 October 2019
- Published by Wiley in Chemistry – A European Journal
- Vol. 25 (66) , 15050-15054
Light‐Induced Tetrazole‐Quinone 1,3‐Dipolar Cycloadditions
Quinones were firstly used as dipolarophiles in a photoclick 1,3‐cycloaddition with 2,5‐diaryltetrazoles, as photoactivatable predipoles, providing a novel and efficient access to three types of pyrazole‐fused quinones (indazoledione derivatives). Distinctive features of this protocol include the use of light as the unique reagent and readily available, stable, and easy to handle starting materials and good to excellent yields. Photophysical and electrochemical properties of the quinones and their potential application as photoredox catalysts are also detailed.
- Open Access
Multifunctional Albumin-Stabilized Gold Nanoclusters for the Reduction of Cancer Stem Cells
Controlled delivery of multiple chemotherapeutics can improve the effectiveness of treatments and reduce side effects and relapses. Here in, we used albumin-stabilized gold nanoclusters modified with doxorubicin and SN38 (AuNCs-DS) as combined therapy for cancer. The chemotherapeutics are conjugated to the nanostructures using linkers that release them when exposed to different internal stimuli (Glutathione and pH). This system has shown potent antitumor activity against breast and pancreatic cancer cells. Our studies indicate that the antineoplastic activity observed may be related to the reinforced DNA damage generated by the combination of the drugs. Moreover, this system presented antineoplastic activity against mammospheres, a culturing model for cancer stem cells, leading to an efficient reduction of the number of oncospheres and their size. In summary, the nanostructures reported here are promising carriers for combination therapy against cancer and particularly to cancer stem cells.
Open AccessMultifunctional Albumin-Stabilized Gold Nanoclusters for the Reduction of Cancer Stem Cells
Controlled delivery of multiple chemotherapeutics can improve the effectiveness of treatments and reduce side effects and relapses. Here in, we used albumin-stabilized gold nanoclusters modified with doxorubicin and SN38 (AuNCs-DS) as combined therapy for cancer. The chemotherapeutics are conjugated to the nanostructures using linkers that release them when exposed to different internal stimuli (Glutathione and pH). This system has shown potent antitumor activity against breast and pancreatic cancer cells. Our studies indicate that the antineoplastic activity observed may be related to the reinforced DNA damage generated by the combination of the drugs. Moreover, this system presented antineoplastic activity against mammospheres, a culturing model for cancer stem cells, leading to an efficient reduction of the number of oncospheres and their size. In summary, the nanostructures reported here are promising carriers for combination therapy against cancer and particularly to cancer stem cells.
- Open Access
- 25 September 2018
- Published by MDPI AG in Biomimetics
- Vol. 3 (4) , 28
Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults and around half of the patients develop metastasis and die shortly after because of the lack of effective therapies for metastatic UM. Consequently, new therapeutic approaches to this disease are welcome. In this regard, microRNAs have been shown to have a key role in neoplasia progression and have the potential to be used as therapeutic tools. In addition, in different cancers including UM, a particular microRNA signature appears that is different from healthy cells. Thus, restoring the regular levels of microRNAs could restore the normal behavior of cells. In this study, four microRNAs downregulated in UM have been chosen to reprogram cancer cells, to promote cell death or increase their sensitivity to the chemotherapeutic SN38. Furthermore, to improve the internalization, stability and/or solubility of the therapeutic molecules employed in this approach, gold nanoparticles (AuNPs) were used as carriers. Remarkably, this study found a synergistic effect when the four oligonucleotides were employed and when the chemotherapeutic drug was added.
- 25 September 2018
- Published by MDPI AG in Biomimetics
- Vol. 3 (4) , 28
Open AccessReprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults and around half of the patients develop metastasis and die shortly after because of the lack of effective therapies for metastatic UM. Consequently, new therapeutic approaches to this disease are welcome. In this regard, microRNAs have been shown to have a key role in neoplasia progression and have the potential to be used as therapeutic tools. In addition, in different cancers including UM, a particular microRNA signature appears that is different from healthy cells. Thus, restoring the regular levels of microRNAs could restore the normal behavior of cells. In this study, four microRNAs downregulated in UM have been chosen to reprogram cancer cells, to promote cell death or increase their sensitivity to the chemotherapeutic SN38. Furthermore, to improve the internalization, stability and/or solubility of the therapeutic molecules employed in this approach, gold nanoparticles (AuNPs) were used as carriers. Remarkably, this study found a synergistic effect when the four oligonucleotides were employed and when the chemotherapeutic drug was added.